Callan JMB reports FY 2025 revenue down 14% to $5.7M; operating loss widens to $7.0M

CALLAN JMB INC.

Revenue $5.7M vs $6.6M in 2024; gross profit $2.1M vs $2.6M.
Operating loss of $7.0M, up from $2.3M loss in 2024 due to IPO costs.
SG&A expenses surged to $8.6M from $4.8M, driven by IPO-related professional fees.
Chicago emergency contract extended through June 2026 with $1.5M increase to $9.1M total.
New Oregon Health Authority five-year contract; entered food sampling sector.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CALLAN JMB INC. reported the twelve months ended December 31, 2025 results: revenue $5.7 million.

Period: the twelve months ended December 31, 2025
Revenue: $5.7 million
Result: reported results

Exact text from the filing

Revenues for the twelve months ended December 31, 2025, was $5.7 million compared to $6.6 million for the twelve months ended December 31, 2024.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

CALLAN JMB INC. reported the full year ended December 31, 2025 results: revenue $5.7 million.

Period: the full year ended December 31, 2025
Revenue: $5.7 million
Result: reported results

Exact text from the filing

device without downloading additional software. Financial Highlights for the Full Year Ended December 31, 2025: ● Revenues for the twelve months ended December 31, 2025, was $5.7 million compared to $6.6 million for the twelve months ended December 31, 2024. The decrease in revenue was due to the decrease in demand for our emergency preparedness services by

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

CALLAN JMB INC. filing history →

Source: SEC EDGAR

accession 0001493152-26-014140

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.